Project Klinische Studie

Basic data

Title:
Klinische Studie
Duration:
12/04/2017 to 30/11/2021
Abstract / short description:
"A multicenter, open Label, study to assess the sefety and efficacy of Risankizumab for maintenance in moderate to severe plaque psoriasis (LIMMITLESS)"
Folgestudie der BI 1311.3
Keywords:
psoriasis
Schuppenflechte
psoriasis therapeutics
Psoriasis Therapeutika
clinical trial
klinische Studie
dermatology
Dermatologie

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Wiesbaden, Hessen, Germany
Help

will be deleted permanently. This cannot be undone.